Harrow Health Inc (HROW) — Capital Reinvestment Ratio
Latest as of December 2025:
0.04x
Harrow Health Inc (HROW) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($8.41 Million) in capital expenditures ($341.00K). See Harrow Health Inc (HROW) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$8.41 Million
USD
Capital Expenditures
$341.00K
USD
Data as of
Dec 2025
Most recent filing
Harrow Health Inc Capital Reinvestment Ratio (2018–2025)
This chart tracks Harrow Health Inc's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Harrow Health Inc (2018–2025)
Year-by-year Capital Reinvestment Ratio for Harrow Health Inc from 2018 to 2025. For live market cap and broader valuation context, see HROW market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $43.86 Million | $887.00K | ▼ -99.9% |
| 2023 | 39.73x | $3.84 Million | $152.55 Million | ▲ +771.4% |
| 2022 | 4.56x | $1.71 Million | $7.77 Million | ▼ -18.7% |
| 2021 | 5.61x | $5.08 Million | $28.51 Million | ▲ +190.1% |
| 2019 | 1.93x | $950.00K | $1.84 Million | ▼ -39.7% |
| 2018 | 3.21x | $687.00K | $2.20 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow